SMITH BRIAN 4
4 · ORASURE TECHNOLOGIES INC · Filed Feb 20, 2018
Insider Transaction Report
Form 4
SMITH BRIAN
SVP, Molecular Solutions
Transactions
- Exercise/Conversion
Common stock
2018-02-16$5.96/sh+10,000$59,590→ 28,075 total - Sale
Common stock
2018-02-15$17.95/sh−10,000$179,450→ 18,075 total - Sale
Common stock
2018-02-16$18.00/sh−10,000$180,010→ 18,075 total - Exercise/Conversion
Nonqualified stock options
2018-02-16−10,000→ 0 totalExercise: $5.96Exp: 2023-12-20→ Common stock (10,000 underlying) - Exercise/Conversion
Common stock
2018-02-15$5.96/sh+10,000$59,590→ 28,075 total - Exercise/Conversion
Nonqualified stock options
2018-02-15−10,000→ 10,000 totalExercise: $5.96Exp: 2023-12-20→ Common stock (10,000 underlying)
Footnotes (1)
- [F1]Nonqualified stock options granted on December 20, 2013, vesting and exercisable over a four-year period, with one-fourth of the options vesting on the first anniversary date of the grant and the remainder vesting ratably on a monthly basis, over the remaining 36 months.